The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Role of antiemetic prophylaxis for breast cancer (BC) patients treated with anti-HER2 or anti-VEGF monoclonal antibodies.
Massimiliano Alu
No relevant relationships to disclose
Giuseppe Bronte
No relevant relationships to disclose
Antonio Russo
No relevant relationships to disclose
Antonella Usset
No relevant relationships to disclose
Sceila Affronti
No relevant relationships to disclose
Giovanni Orlando
No relevant relationships to disclose
Maria Antonietta Aspanò
No relevant relationships to disclose
Silvana Bavetta
No relevant relationships to disclose
Paolo Amari
No relevant relationships to disclose
Giuseppe Galanti
No relevant relationships to disclose
Vincenzo Adamo
No relevant relationships to disclose
Livio Blasi
No relevant relationships to disclose